Bioorganic & Medicinal Chemistry 2007-07-15

Toward the development of chemoprevention agents. Part 1: Design, synthesis, and anti-inflammatory activities of a new class of 2,5-disubstituted-dioxacycloalkanes.

Keli Gu, Lanrong Bi, Ming Zhao, Chao Wang, Jingfang Ju, Shiqi Peng

Index: Bioorg. Med. Chem. 15 , 4775-99, (2007)

Full Text: HTML

Abstract

A new class of 2,5-disubstituted-dioxacycloalkanes were designed and synthesized via stereoselective synthetic method as cancer chemoprevention agents. The anti-inflammatory activities of these compounds were tested using the xylene-induced mouse ear edema model. Some of these compounds exhibited comparable or better anti-inflammatory activities than that of aspirin suggesting that they can be further developed as potential anti-inflammatory drug lead compounds. In addition, treatment of these anti-inflammatory agents did not prolong tail bleeding time in mice. The structure/activity relationships were also analyzed among these compounds.

Related Compounds

Structure Name/CAS No. Articles
4-Chlorobenzaldehyde Structure 4-Chlorobenzaldehyde
CAS:104-88-1
Aspirin Structure Aspirin
CAS:50-78-2
Benzaldehyde Structure Benzaldehyde
CAS:100-52-7
Cinnamic aldehyde Structure Cinnamic aldehyde
CAS:14371-10-9
p-Tolualdehyde Structure p-Tolualdehyde
CAS:104-87-0
Cinnamaldehyde Structure Cinnamaldehyde
CAS:104-55-2